Joseph P. Lucia & Associates, LLC Ocugen, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$2.34 - $4.72 $2,396 - $4,833	1,024 New	1,024 $3,000
Q4 2021 Feb 04, 2022	SELL	$4.38 - $15.67 $4,485 - $16,046	-1,024 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$1.66 - $15.81 $2,656 - $25,296	-1,600 Reduced 60.98%	1,024 $7,000
Q4 2020 Jan 29, 2021	BUY	$0.28 - $2.6 $734 - $6,822	2,624 New	2,624 $5,000
Q3 2020 Oct 20, 2020	SELL	$0.2 - $0.72 $204 - $737	-1,024 Closed	0 $0
Q4 2019 Jan 23, 2020	SELL	$0.27 - $2.19 $22 - $181	-83 Reduced 7.5%	1,024 $1,000
Q3 2019 Oct 15, 2019	BUY	$2.85 - $16.26 $3,154 - $17,999	1,107 New	1,107 $3,000

123

68.6M

478K

253K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $121M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.